Intrexon reported $-19251000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Agenus AGEN:US $ -48.32M 17.19M
Amgen AMGN:US $ 1476M 423M
Anika Therapeutics ANIK:US $ -2.93M 2.86M
Arrowhead Research ARWR:US $ 44.37M 107.24M
AstraZeneca AZN:LN 386M 733M
Bristol Myers Squibb BMY:US $ 1278M 1094M
Chemocentryx CCXI:US $ -38.61M 1.92M
Gilead Sciences GILD:US $ 19M 363M
GlaxoSmithKline GSK:LN 1802M 1053M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Immunogen IMGN:US $ -24.14M 13.03M
Intrexon XON:US $ -19.25M 5.78M
Karyopharm Therapeutics KPTI:US $ -41399000 80.12M
Ligand Pharmaceuticals LGND:US $ -15.38M 9.97M
Macrogenics MGNX:US $ -66.44M 8.42M
Mannkind MNKD:US $ -26M 2.06M
Merk MRK:US $ 4310M 552M
Novartis NOVN:VX SF 2222M 14086M
Peregrine Pharmaceuticals PPHM:US $ 2.25M 1.27M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.8M
Sangamo Biosciences SGMO:US $ -43.98M 6.48M
Thermo Fisher Scientific TMO:US $ 2215M 557M
Veracyte VCYT:US $ -14.46M 3.93M
Xencor XNCR:US $ 23.59M 49.47M
YTE INCY:US $ 37.99M 525.86M
Ziopharm Oncology ZIOP:US $ -9.79M 2.01M